Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5252
Peer-review started: April 20, 2023
First decision: June 7, 2023
Revised: June 10, 2023
Accepted: July 3, 2023
Article in press: July 3, 2023
Published online: August 6, 2023
Processing time: 104 Days and 12.6 Hours
Core Tip: As a systemic disease, coronavirus disease 2019 (COVID-19) can impact various organs in the human body, including the autonomic nervous system and gastrointestinal tract. Our team conducted a systematic review to better understand the clinical range of COVID-19's impact on gastrointestinal autonomic dysfunction. We examined the clinical manifestations, potential mechanisms, diagnosis, differential diagnosis, effects on quality of life, prognosis, management, and prevention of COVID-19-induced gastrointestinal autonomic dysfunction. Most of the literature suggests that gastrointestinal autonomic dysfunction can be severe and negatively impact a patient's quality of life and prognosis. As a result, a multidisciplinary approach is needed to manage this dysfunction. However, further research is necessary to study COVID-19-induced gastrointestinal autonomic dysfunction effectively.
